Want help reviewing this study?
Study ID: NCT04478838. We help you review the study, but cannot decide medical eligibility.
RecruitingNCT04478838
"Extended" (Alternate Day) Antipsychotic Dosing
This study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.
Schizophrenia, Drug Administration Schedule, ...DrugOver 18 Years
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- Toronto, CanadaSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 6, 2022
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 120
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT04478838
- Official title
- "Re-examining Maintenance Antipsychotic Treatment in Schizophrenia: "Extended" Antipsychotic Dosing"
Recruitment & locations
RecruitingToronto
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Risperidone, Olanzapine and paliperidone.
Who can participate?
This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
RecruitingNCT06126224
KarXT for Schizophrenia
The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ... Confirm recruitment at each site. It is testing KarXT for Schizophrenia.
RecruitingNCT06887192
ML-007C-MA for Schizophrenia
The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Canada, ... Confirm recruitment at each site. It is testing ML-007C-MA for Schizophrenia.
RecruitingNCT06947941
Safety and Efficacy of KarXT + KarX-EC for Schizophrenia
The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ... Confirm recruitment at each site. It is testing Safety and Efficacy of KarXT + KarX-EC for Schizophrenia.